loadpatents
Patent applications and USPTO patent grants for FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR.The latest application filed is for "method for optical measuring variations of cell membrane conductance".
Patent | Date |
---|---|
Gene vector Grant 9,556,438 - Naldini , et al. January 31, 2 | 2017-01-31 |
Method For Optical Measuring Variations Of Cell Membrane Conductance App 20120149052 - Grohovaz; Fabio ;   et al. | 2012-06-14 |
Use Of Common Gamma Chain Cytokines For The Visualization, Isolation And Genetic Modification Of Memory T Lymphocytes App 20120027802 - BONINI; Maria Chiara ;   et al. | 2012-02-02 |
Skeletal muscle periangioblasts and cardiac mesangioblasts, method for isolation and uses thereof Grant 8,071,380 - Cossu , et al. December 6, 2 | 2011-12-06 |
Gene Vector For Inducing Transgene-specific Immune Tolerance App 20110218234 - Annoni; Andrea ;   et al. | 2011-09-08 |
Uses Of Conglutin-gamma App 20110117226 - Terruzzi; Ileana Marina ;   et al. | 2011-05-19 |
Nitrogen Independence Identifies A Highly Malignant Population Of Tumor Stem Cells App 20100323385 - Galli; Rossella | 2010-12-23 |
Hematopoietic Lineage Cell Specific Protein (HS1) as a Marker for Lymphoid Malignancy App 20100297137 - Caligaris-Cappio; Federico ;   et al. | 2010-11-25 |
Monocyte cell Grant 7,833,789 - Naldini , et al. November 16, 2 | 2010-11-16 |
Peptides comprising an isoDGR motif Grant 7,795,386 - Corti , et al. September 14, 2 | 2010-09-14 |
Modified Cytokines For Use In Cancer Therapy App 20100196458 - CORTI; Angelo | 2010-08-05 |
Antibody against uPA/uPAR Grant 7,737,256 - Blasi , et al. June 15, 2 | 2010-06-15 |
Gene Vector App 20100041737 - Naldini; Luigi ;   et al. | 2010-02-18 |
Tolerogenic Dendritic Cells, Method For Their Production And Uses Therof App 20100041145 - Gregori; Silvia Adriana ;   et al. | 2010-02-18 |
Skeletal Muscle Periangioblasts And Cardiac Mesangioblasts, Method For Isolation And Uses Thereof App 20090317909 - Cossu; Giulio ;   et al. | 2009-12-24 |
Modified cytokines for use in cancer therapy Grant 7,622,556 - Corti November 24, 2 | 2009-11-24 |
Modified cytokines for use in cancer therapy Grant 7,622,105 - Corti November 24, 2 | 2009-11-24 |
Modified cytokines for use in cancer therapy Grant 7,476,721 - Corti January 13, 2 | 2009-01-13 |
Modified cytokines for use in cancer therapy Grant 7,309,694 - Corti December 18, 2 | 2007-12-18 |
Use of oversulfated polysaccharides as inhibitors of HIV Grant 7,268,122 - Zoppetti , et al. September 11, 2 | 2007-09-11 |
Modified cytokines for use in cancer therapy App 20070041939 - Corti; Angelo | 2007-02-22 |
RANTES mutants and therapeutic applications thereof Grant 7,164,000 - Lusso , et al. January 16, 2 | 2007-01-16 |
Modified cytokines for use in cancer therapy Grant 7,150,869 - Corti December 19, 2 | 2006-12-19 |
Modified cytokines for use in cancer therapy Grant 7,109,303 - Corti September 19, 2 | 2006-09-19 |
Modified cytokines for use in cancer therapy App 20060115451 - Corti; Angelo | 2006-06-01 |
Method for the quantitative detection of nucleic acids Grant 7,029,843 - Locatelli , et al. April 18, 2 | 2006-04-18 |
Modified cytokines for use in cancer therapy App 20050265965 - Corti, Angelo | 2005-12-01 |
RANTES derived peptides with anti-HIV activity Grant 6,709,649 - Lusso , et al. March 23, 2 | 2004-03-23 |
Modified cytokines for use in cancer therapy App 20040018171 - Corti, Angelo | 2004-01-29 |
Modified cytokines for use in cancer therapy App 20030157056 - Corti, Angelo | 2003-08-21 |
Modified cytokines for use in cancer therapy App 20030157055 - Corti, Angelo | 2003-08-21 |
Rantes mutants and therapeutic applications thereof Grant 6,608,177 - Lusso , et al. August 19, 2 | 2003-08-19 |
NCAGE Code | AD121 | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR |
CAGE Code | AD121 | FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR OSPEDALE SAN RAFFAELE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.